Legend Biotech Corp Adjustments For Fair Value Gains Losses
Legend Biotech Corp (LEGN) reported Adjustments For Fair Value Gains Losses of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFairValueGainsLosses · last filed 2026-03-10
- Legend Biotech Corp adjustments for fair value gains losses for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Legend Biotech Corp adjustments for fair value gains losses for the quarter ending 2025-03-31 was $0.00.
- Legend Biotech Corp adjustments for fair value gains losses for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Legend Biotech Corp adjustments for fair value gains losses for the quarter ending 2024-09-30 was $201.00K.
| Period end | Adjustments For Fair Value Gains Losses 3 month | Adjustments For Fair Value Gains Losses 6 month | Adjustments For Fair Value Gains Losses 9 month | Adjustments For Fair Value Gains Losses 12 month | Adjustments For Fair Value Gains Losses 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-10 | ||||
| 2025-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | $0.00 6-K · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-10 | $201.00K derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | $0.00 6-K · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $201.00K derived: sum of 3 quarters · filed 2026-03-10 | $449.00K derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $201.00K derived: sum of 2 quarters · filed 2026-03-10 | $449.00K derived: sum of 3 quarters · filed 2026-03-10 | $0.00 20-F · filed 2026-03-10 | |
| 2024-09-30 | $201.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $449.00K derived: sum of 2 quarters · filed 2025-08-11 | $0.00 6-K · filed 2024-11-12 | $92.00K derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | $248.00K derived: 6-K 6 month − 6-K 3 month · filed 2025-08-11 | -$201.00K 6-K · filed 2025-08-11 | -$109.00K derived: sum of 3 quarters · filed 2026-03-10 | -$145.00K derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | -$449.00K 6-K · filed 2025-05-13 | -$357.00K derived: sum of 2 quarters · filed 2026-03-10 | -$393.00K derived: sum of 3 quarters · filed 2026-03-10 | -$444.00K derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | $92.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $56.00K derived: sum of 2 quarters · filed 2026-03-10 | $5.00K derived: sum of 3 quarters · filed 2026-03-10 | -$700.00K 20-F · filed 2026-03-10 | -$663.00K 20-F · filed 2024-03-19 |
| 2023-09-30 | -$36.00K derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$87.00K derived: sum of 2 quarters · filed 2024-11-12 | -$792.00K 6-K · filed 2024-11-12 | -$1.28M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | -$51.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | -$756.00K 6-K · filed 2024-08-09 | -$1.25M derived: sum of 3 quarters · filed 2025-03-11 | -$1.36M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | -$705.00K 6-K · filed 2024-05-13 | -$1.20M derived: sum of 2 quarters · filed 2025-03-11 | -$1.31M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | -$491.00K derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | -$603.00K derived: sum of 2 quarters · filed 2025-03-11 | -$593.00K 20-F · filed 2025-03-11 | ||
| 2022-09-30 | -$112.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | -$102.00K 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $10.00K 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $0.00 20-F · filed 2024-03-19 | ||||
| 2020-12-31 | -$47.00K 20-F · filed 2023-03-30 | ||||
| 2020-06-30 | -$39.00K 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | -$474.00K 20-F/A · filed 2023-02-17 | ||||
| 2018-12-31 | -$89.00K 20-F · filed 2021-04-02 |